1. Cohen S, Levi-Montalcini R, Hamburger VA. Nerve Growth-Stimulating Factor Isolated From Sarcomas 37 and 180. Proc Natl Acad Sci 1954; 40: 1014–8.
2. Levi-Montalcini R, Cohen S. In Vitro and In Vivo Effects of a Nerve Growth-Stimulating Agent Isolated From Snake Venom. Proc Natl Acad Sci 1956; 42 (9): 695–9.
3. Levi-Montalcini R. The nerve growth factor: thirty-five years later. EMBO J 1987; 6: 1145–54.
4. Гомазков О.А. Нейротрофическая регуляция и стволовые клетки мозга. ИКАР. 2006.
5. Guzman R. Cellular stroke therapy: from cell replacement to trophic support. Expert Review of Cardiovascular Therapy 2009; 7 (1): 1187–90.
6. Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 2003; 29: 211–30.
7. Enciu AM, Nicolescu MI, Manole CG et al. Neuroregeneration in neurodegenerative disorders. BMC Neurol 2011; 11: 75.

8. Hock C, Drasch G, Golombowski S et al. Increased blood mercury levels in patients with Alzheimer's disease. J Neural Transm 1998; 105 (1): 59–68.
9. Higgins GA, Mufson EJ. NGF gene expression is decreased in the nucleus basalis in Alzheimer disease. Exper Neurol 1989; 106: 222–31.
10. Laske C, Stransky E, Leyhe T et al. Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 2006; 113 (9): 1217–24.
11. Schaub RT, Anders D, Golz G et al. Serum nerve growth factor concentration and its role in the preclinical stage of dementia. Am J Psychiatry 2002; 159 (7): 1227–9.
12. Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 2003; 29: 211–30.
13. Tong M, Dong M, de la Monte SM. Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. J Alzheimers Dis 2009; 16 (3): 585–99.
14. Peng S, Garzon DJ, Marchese M et al. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci 2009; 29 (29): 9321.
15. Ginsberg SD, Che S, Wuu J et al. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem 2006; 97 (2): 475–87.
16. Freude S, Schilbach K, Schubert M. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease. Curr Alzheimer Res 2009; 6 (3): 213–23.
17. Moloney AM, Griffin RJ, Timmons S et al. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 2010; 31 (2): 224–43.
18. Price R et al. Advances in small molecules promoting neurotrophic function. Pharm Therap 2007; 115 (2): 292–306.
19. Ibáñez CF, Ebendal T, Persson H. Chimeric molecules with multiple neurotrophic activities reveal structural elements determining the specificities of NGF and BDNF. EMBO J 1991; 10 (8): 2105–10.
20. Hughes AL, Messineo-Jones D, Lad SP, Neet KE. Distinction between differentiation, cell cycle, and apoptosis signals in PC12 cells by the nerve growth factor mutant delta9/13, which is selective for the p75 neurotrophin receptor. J Neurosci Res 2001; 63 (1): 10–9.
21. Massa SM, Yang T, Xie Y et al. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Invest 2010; 120 (5): 1774–85.
22. Островская Р.У., Гудашева Т.А., Цаплина А.П. и др. Ноопепт стимулирует экспрессию NGF и BDNF в гиппокампе крысы. Бюлл. эксп. биол. мед. 2008; 148 (3): 334–7.
23. Shin MK, Kim HG, Kim KL. A novel trimeric peptide, Neuropep-1-stimulating brain-derived neurotrophic factor expression in rat brain improves spatial learning and memory as measured by the Y-maze and Morris water maze (Neuropep 1=Met-Val-Gly). J Neurochem 2011; 116 (2): 205–16.
24. Windisch M, Gschanes A, Hutter-Paier B. Neurotrophic activities and therapeutic experience with a brain derived peptide preparation. J Neural Transm Suppl 1998; 53: 289–29.
25. Громова О.А., Третьяков В.Е., Мошковский С.А. и др. Олигопептидная мембранная фракция церебролизина. Журн. неврол. и психиатр. им. С.С.Корсакова. 2006; 106 (7): 68–7.
26. Chen H, Tung YC, Li B et al. Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis. Neurobiol Aging 2007; 28: 1148–62.
27. Jafferali S, Dumont Y, Sotty F et al. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains. Synapse 2000; 38 (4): 450–9.
28. Garcia P, Youssef I, Utvik JK et al. Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease. J Neurosci 2010; 30 (22): 7516–27.
29. Sun M, Kong L, Wang X et al. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease. Brain Res 2005; 1052 (2): 119–29.

О.А.Гомазков 

ФГБУ НИИ биомедицинской химии им. В.Н.Ореховича РАМН, Москва